- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 29, 2025 | 28.63M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $300.63M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $278.03M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $25.39M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $16.96M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $53.05M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $45.42M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $388.34M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $354.78M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $585.26M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $543.16M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 28.62M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $172K |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.43M |
| Capex | Q1 2025 · Mar 31, 2024 | $6.82M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $27.17M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $415.32M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $393.1M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.78 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.79 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.85M |
| Net Income | Q1 2025 · Mar 31, 2024 | $22.44M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $25.76M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $30.61M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $41.08M |
| Revenue | Q1 2025 · Mar 31, 2024 | $71.69M |